Interview with Rodrigo Iturralde, Director, Randall Laboratories
When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how…
The National Institute of Psychiatry Ramón de la Fuente is a decentralized public institution part of the system of National Institutes of Health in Mexico. Founded in 1976 the functions of the Institute are: to conduct scientific research, to instruct qualified personnel to conduct these investigations, to train professionals and technicians in these fields, to treat psychiatric patients and to act as an advisor to other official and private organisms. The Institute participates in the development of health policies by coordinating with institutions at national level with both the government and civil society, by helping in the adoption of new policies in the areas of mental health and substance abuse in its role as member of the National Council against Addictions and organism in charge of mental health in the country. Since 1976 the Institute has been designated as a WHO/PAHO Collaborating Centre and been continuously re-designated every four years until 2015. The Institute possesses three research branches― neuroscience, clinical, epidemiological, and psychosocial research — an education office and an area of clinical services.
When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how…
Please can you tell our readers a little bit more about the history of Stendhal, and its major milestones along the way since its takeover in 1997? Stendhal is a…
Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”.…
Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this acquisition affect Nycomed’s Latin…
The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory…
This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we last interviewed you in 2008?…
This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now we’re delighted to be…
There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local plant rule. COFEPRIS has…
Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its…
Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its…
See our Cookie Privacy Policy Here